German Chancellor Angela Merkel arrives for a weekly government cabinet meeting on June 30, 2021 in Berlin. (Photo: Maja Hitij/Getty Images)
Dems Request Meeting With Merkel to Discuss Germany's 'Blockade' of Vaccine Patent Waiver
U.S. members of Congress are pushing the German leader to stop "putting industry IP monopolies as a priority over people."
With the ultra-contagious Delta variant fueling devastating waves of coronavirus infections across the globe, a group of House Democrats is demanding a meeting with German Chancellor Angela Merkel to discuss her ongoing "blockade" of a temporary patent waiver for Covid-19 vaccines--a popular proposal aimed at quickly boosting supply of the life-saving shots.
"Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
--Letter
"We are troubled by the European Union's continuing opposition to this initiative, which we understand is a position led by Germany within the E.U.," nine House Democrats wrote in a letter (pdf) late Monday to Emily Haber, Germany's ambassador to the United States.
The letter comes just days before Merkel is set to arrive in the United States for a July 15 White House visit, during which the German leader and U.S. President Joe Biden are expected to discuss a range of pressing issues, including the coronavirus pandemic and the climate crisis.
In their letter, the group of House Democrats led by Rep. Jan Schakowsky of Illinois noted that the U.S. and "almost every other" member of the World Trade Organization (WTO) supports the proposed intellectual property waiver, which South Africa and India first introduced in October.
"Scaling up much greater production of mRNA vaccines is necessary to save millions of lives and livelihoods," the lawmakers wrote. "Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
"Chancellor Merkel joining President Biden in supporting the waiver would lock in her legacy worldwide and that of Germany as heroes taking extraordinary efforts to protect people worldwide from the worst health threat in 100 years," they continued. "Chancellor Merkel's failure to do so, and thus putting industry IP monopolies as a priority over people, will also be understood globally if that is the outcome."
Biden won widespread applause after he endorsed the patent waiver in May, but little progress has been made toward a final agreement at the WTO as Germany, the United Kingdom, Canada, and a handful of other wealthy countries continue to stonewall the proposal. In the weeks since he announced his support for the waiver, Biden has done little to publicly pressure U.S. allies to follow suit, prompting criticism from advocacy groups and experts.
The rapid spread of the Delta variant has increased pressure on the leaders of rich nations to end their obstruction of the waiver, which would suspend intellectual property barriers that are preventing manufacturers around the world from producing generic vaccines for developing countries.
In the absence of a patent waiver, low-income nations are struggling to get their vaccination drives off the ground due to the artificially scarce supply of doses and other factors, including pharmaceutical companies' refusal to share essential manufacturing technology that was developed with public funding. Just 1% of people in low-income countries have received at least one coronavirus vaccine dose, according to the latest figures from Our World in Data.
Research published last week in the journal Nature found that just one dose of the Pfizer or AstraZeneca vaccine "barely inhibited" the Delta variant, which is ripping through undervaccinated regions of the world such as Africa and South America. The strain has also been detected in all 50 states of the U.S., and it is hammering pockets of the nation with low vaccination rates.
"We are experiencing a worsening public health emergency that further threatens lives, livelihoods, and a sound global economic recovery," Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, warned Monday. "It is definitely worse in places that have very few vaccines, but the pandemic is not over, anywhere."
Public health campaigners across the U.S. are planning to greet Merkel with nationwide protests demanding that she end her opposition to the patent waiver and join global efforts to break the pharmaceutical industry's stranglehold on vaccine production.
"Covid-19 is raging through the many nations with limited vaccine access. Poor nations' access may lag until 2024, destroying lives and livelihoods and increasing chances a vaccine-resistant variant develops," said consumer advocacy group Public Citizen, one of the organizations behind the protests.
"Merkel's singular role as the obstacle has made the summit a critical test of whether President Joe Biden can deliver on his goal of a TRIPS waiver unlocking global vaccine and treatment access--or his initiative to save tens of millions of live could fail despite his historic support, as well as Merkel's chance to cement her legacy as a humanitarian, not a Big Pharma shill," the group added.
Urgent. It's never been this bad.
Dear Common Dreams reader, It’s been nearly 30 years since I co-founded Common Dreams with my late wife, Lina Newhouser. We had the radical notion that journalism should serve the public good, not corporate profits. It was clear to us from the outset what it would take to build such a project. No paid advertisements. No corporate sponsors. No millionaire publisher telling us what to think or do. Many people said we wouldn't last a year, but we proved those doubters wrong. Together with a tremendous team of journalists and dedicated staff, we built an independent media outlet free from the constraints of profits and corporate control. Our mission from the outset was simple. To inform. To inspire. To ignite change for the common good. Building Common Dreams was not easy. Our survival was never guaranteed. When you take on the most powerful forces—Wall Street greed, fossil fuel industry destruction, Big Tech lobbyists, and uber-rich oligarchs who have spent billions upon billions rigging the economy and democracy in their favor—the only bulwark you have is supporters who believe in your work. But here’s the urgent message from me today. It’s never been this bad out there. And it’s never been this hard to keep us going. At the very moment Common Dreams is most needed and doing some of its best and most important work, the threats we face are intensifying. Right now, with just three days to go in our Spring Campaign, we're falling short of our make-or-break goal. When everyone does the little they can afford, we are strong. But if that support retreats or dries up, so do we. Can you make a gift right now to make sure Common Dreams not only survives but thrives? There is no backup plan or rainy day fund. There is only you. —Craig Brown, Co-founder |
With the ultra-contagious Delta variant fueling devastating waves of coronavirus infections across the globe, a group of House Democrats is demanding a meeting with German Chancellor Angela Merkel to discuss her ongoing "blockade" of a temporary patent waiver for Covid-19 vaccines--a popular proposal aimed at quickly boosting supply of the life-saving shots.
"Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
--Letter
"We are troubled by the European Union's continuing opposition to this initiative, which we understand is a position led by Germany within the E.U.," nine House Democrats wrote in a letter (pdf) late Monday to Emily Haber, Germany's ambassador to the United States.
The letter comes just days before Merkel is set to arrive in the United States for a July 15 White House visit, during which the German leader and U.S. President Joe Biden are expected to discuss a range of pressing issues, including the coronavirus pandemic and the climate crisis.
In their letter, the group of House Democrats led by Rep. Jan Schakowsky of Illinois noted that the U.S. and "almost every other" member of the World Trade Organization (WTO) supports the proposed intellectual property waiver, which South Africa and India first introduced in October.
"Scaling up much greater production of mRNA vaccines is necessary to save millions of lives and livelihoods," the lawmakers wrote. "Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
"Chancellor Merkel joining President Biden in supporting the waiver would lock in her legacy worldwide and that of Germany as heroes taking extraordinary efforts to protect people worldwide from the worst health threat in 100 years," they continued. "Chancellor Merkel's failure to do so, and thus putting industry IP monopolies as a priority over people, will also be understood globally if that is the outcome."
Biden won widespread applause after he endorsed the patent waiver in May, but little progress has been made toward a final agreement at the WTO as Germany, the United Kingdom, Canada, and a handful of other wealthy countries continue to stonewall the proposal. In the weeks since he announced his support for the waiver, Biden has done little to publicly pressure U.S. allies to follow suit, prompting criticism from advocacy groups and experts.
The rapid spread of the Delta variant has increased pressure on the leaders of rich nations to end their obstruction of the waiver, which would suspend intellectual property barriers that are preventing manufacturers around the world from producing generic vaccines for developing countries.
In the absence of a patent waiver, low-income nations are struggling to get their vaccination drives off the ground due to the artificially scarce supply of doses and other factors, including pharmaceutical companies' refusal to share essential manufacturing technology that was developed with public funding. Just 1% of people in low-income countries have received at least one coronavirus vaccine dose, according to the latest figures from Our World in Data.
Research published last week in the journal Nature found that just one dose of the Pfizer or AstraZeneca vaccine "barely inhibited" the Delta variant, which is ripping through undervaccinated regions of the world such as Africa and South America. The strain has also been detected in all 50 states of the U.S., and it is hammering pockets of the nation with low vaccination rates.
"We are experiencing a worsening public health emergency that further threatens lives, livelihoods, and a sound global economic recovery," Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, warned Monday. "It is definitely worse in places that have very few vaccines, but the pandemic is not over, anywhere."
Public health campaigners across the U.S. are planning to greet Merkel with nationwide protests demanding that she end her opposition to the patent waiver and join global efforts to break the pharmaceutical industry's stranglehold on vaccine production.
"Covid-19 is raging through the many nations with limited vaccine access. Poor nations' access may lag until 2024, destroying lives and livelihoods and increasing chances a vaccine-resistant variant develops," said consumer advocacy group Public Citizen, one of the organizations behind the protests.
"Merkel's singular role as the obstacle has made the summit a critical test of whether President Joe Biden can deliver on his goal of a TRIPS waiver unlocking global vaccine and treatment access--or his initiative to save tens of millions of live could fail despite his historic support, as well as Merkel's chance to cement her legacy as a humanitarian, not a Big Pharma shill," the group added.
With the ultra-contagious Delta variant fueling devastating waves of coronavirus infections across the globe, a group of House Democrats is demanding a meeting with German Chancellor Angela Merkel to discuss her ongoing "blockade" of a temporary patent waiver for Covid-19 vaccines--a popular proposal aimed at quickly boosting supply of the life-saving shots.
"Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
--Letter
"We are troubled by the European Union's continuing opposition to this initiative, which we understand is a position led by Germany within the E.U.," nine House Democrats wrote in a letter (pdf) late Monday to Emily Haber, Germany's ambassador to the United States.
The letter comes just days before Merkel is set to arrive in the United States for a July 15 White House visit, during which the German leader and U.S. President Joe Biden are expected to discuss a range of pressing issues, including the coronavirus pandemic and the climate crisis.
In their letter, the group of House Democrats led by Rep. Jan Schakowsky of Illinois noted that the U.S. and "almost every other" member of the World Trade Organization (WTO) supports the proposed intellectual property waiver, which South Africa and India first introduced in October.
"Scaling up much greater production of mRNA vaccines is necessary to save millions of lives and livelihoods," the lawmakers wrote. "Thanks to IP barriers, it is the U.S. and German firms that have the only approved Covid-19 mRNA vaccines that hold the monopoly power to decide if this scale-up will occur."
"Chancellor Merkel joining President Biden in supporting the waiver would lock in her legacy worldwide and that of Germany as heroes taking extraordinary efforts to protect people worldwide from the worst health threat in 100 years," they continued. "Chancellor Merkel's failure to do so, and thus putting industry IP monopolies as a priority over people, will also be understood globally if that is the outcome."
Biden won widespread applause after he endorsed the patent waiver in May, but little progress has been made toward a final agreement at the WTO as Germany, the United Kingdom, Canada, and a handful of other wealthy countries continue to stonewall the proposal. In the weeks since he announced his support for the waiver, Biden has done little to publicly pressure U.S. allies to follow suit, prompting criticism from advocacy groups and experts.
The rapid spread of the Delta variant has increased pressure on the leaders of rich nations to end their obstruction of the waiver, which would suspend intellectual property barriers that are preventing manufacturers around the world from producing generic vaccines for developing countries.
In the absence of a patent waiver, low-income nations are struggling to get their vaccination drives off the ground due to the artificially scarce supply of doses and other factors, including pharmaceutical companies' refusal to share essential manufacturing technology that was developed with public funding. Just 1% of people in low-income countries have received at least one coronavirus vaccine dose, according to the latest figures from Our World in Data.
Research published last week in the journal Nature found that just one dose of the Pfizer or AstraZeneca vaccine "barely inhibited" the Delta variant, which is ripping through undervaccinated regions of the world such as Africa and South America. The strain has also been detected in all 50 states of the U.S., and it is hammering pockets of the nation with low vaccination rates.
"We are experiencing a worsening public health emergency that further threatens lives, livelihoods, and a sound global economic recovery," Tedros Adhanom Ghebreyesus, director-general of the World Health Organization, warned Monday. "It is definitely worse in places that have very few vaccines, but the pandemic is not over, anywhere."
Public health campaigners across the U.S. are planning to greet Merkel with nationwide protests demanding that she end her opposition to the patent waiver and join global efforts to break the pharmaceutical industry's stranglehold on vaccine production.
"Covid-19 is raging through the many nations with limited vaccine access. Poor nations' access may lag until 2024, destroying lives and livelihoods and increasing chances a vaccine-resistant variant develops," said consumer advocacy group Public Citizen, one of the organizations behind the protests.
"Merkel's singular role as the obstacle has made the summit a critical test of whether President Joe Biden can deliver on his goal of a TRIPS waiver unlocking global vaccine and treatment access--or his initiative to save tens of millions of live could fail despite his historic support, as well as Merkel's chance to cement her legacy as a humanitarian, not a Big Pharma shill," the group added.